Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-15 4:06 pm Sale |
2022-12-12 | 13D | Aerovate Therapeutics, Inc. AVTE |
Atlas Venture Fund XII, L.P. | 58,264 8.300% |
-8,691 (-12.98%) |
Filing History |
| 2022-07-20 4:22 pm Sale |
2022-07-15 | 13D | Aerovate Therapeutics, Inc. AVTE |
Atlas Venture Fund XII, L.P. | 66,955 9.600% |
-8,691 (-11.49%) |
Filing History |
| 2022-05-05 4:04 pm Purchase |
2022-04-01 | 13D | Aerovate Therapeutics, Inc. AVTE |
Atlas Venture Fund XII, L.P. | 75,646 10.800% |
75,646 (New Position) |
Filing History |
| 2022-02-14 4:14 pm Purchase |
2021-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE |
Baker Bros. Advisors LP | 52,337 7.500% |
52,337 (New Position) |
Filing History |
| 2022-02-14 3:10 pm Sale |
2021-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE |
Cormorant Asset Management LP | 52,305 7.500% |
-5,714 (-9.85%) |
Filing History |
| 2022-02-14 06:22 am Sale |
2021-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE |
Citadel Advisors LLC | 45,642 6.500% |
-791 (-1.70%) |
Filing History |
| 2021-11-05 4:38 pm Purchase |
2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE |
Atlas Venture Associates XII LLC | 88,682 12.700% |
88,682 (New Position) |
Filing History |
| 2021-07-13 1:49 pm Purchase |
2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE |
Sofinnova Venture Partners X L.P. | 107,431 16.300% |
107,431 (New Position) |
Filing History |
| 2021-07-12 5:13 pm Purchase |
2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE |
RA CAPITAL MANAGEMENT L.P. | 236,114 33.900% |
236,114 (New Position) |
Filing History |
| 2021-07-12 4:19 pm Purchase |
2021-07-02 | 13G | Aerovate Therapeutics, Inc. AVTE |
Cormorant Asset Management LP | 58,020 8.320% |
58,020 (New Position) |
Filing History |
| 2021-07-12 4:03 pm Purchase |
2021-07-02 | 13G | Aerovate Therapeutics, Inc. AVTE |
Citadel Advisors LLC | 46,434 6.700% |
46,434 (New Position) |
Filing History |